Send the following on WhatsApp
Continue to ChatThe dual therapy sirolimus-eluting and CD34 antibody-coated Combo stent (DTS) was designed to further improve early healing. The SORT OUT X trial was a large-scale randomized, multicenter, single-blind, two-arm, non-inferiority trial. The primary endpoint was a composite of cardiac death, myocardial infarction. The DTS did not confirm non-inferiority to the SES for target lesion failure at 12 months in an all-comer population. https://umdaa.co/blogs/1263/randomized-clinical-comparison-of-the-dual-therapy-cd34-antibody-covered-sirolimus-eluting-combo-stent-with-the-sirolimus-eluting-orsiro-stent-in-patients-treated-with-percutaneous-coronary-intervention-the-sort-out-x-trial